How Is Big Pharma Interacting with Tech Startups?
With declining revenues and regulatory hurdles, large pharmaceutical and biotechnology corporations are beginning to look for ways to increase sales of existing drugs and add new sources of revenue. Health IT startups have the potential to solve many of these hurdles, yet on the whole, big pharma has been slow to adopt new innovative technology. This session will look at pharma activity in the the health IT space to date, where it's headed, and what health IT entrepreneurs can do to better appeal to large pharma and biotech.
Presenters
Jennifer Lannon
Life Science Program Mgr
Springboard Enterprises
As Life Science Program Manager for Springboard Enterprises, Jennifer Lannon works closely with the Springboard network and entrepreneurs to run the Life Science Accelerator and Dolphin Tank pitch ...
Show the rest